Telomerase activity and the subunit of telomerase in hydatidiform mole and their relationship with the development of postmolar tumor

Objectives: To investigate the pattern of telomerase activity and the subunit of telomerase in normal placentae and GTD, and to determine the prognostic significance of telomerase activity and the subunit of telomerase in GTD.

Methods: Telomerase activity human telomerase (hTERT) and human telomerase (hTR) expression were analyzed in the initial uterine evacuation specimen of 63 hydatidiform moles (HMs), 42 normal human placental tissues, 17 malignant gestational trophoblastic tumors, primary cultures of normal villi and JAR cell lines by use of the polymerase chain reaction-based telomeric repeat amplification protocol (TRAP) assay and reverse transcription-polymerase chain reaction (RT-PCR) methods.

Results: Telomerase activity was 100% in primary cultures of normal villi and JAR cell lines and in less than 60-day early placental villi, while only 9.1% in greater than 60-day placental villi, 27% in HMs and 58% in malignant trophoblastic tumors. High levels of hTR could be found in all groups. hTR expression was detected in all cases of < 60-day placental villi, in 72.7% > 60-day placental villi, in 87.3% in HMs and 100% in malignant trophoblastic tumors. Telomerase activity and hTERT expression had significant differences among the groups. Telomerase activity was associated with serum hCG levels but not related to other clinical risk factors.

Conclusions: Telomerase activity may be correlated with the development of trophoblastic tumors, and hTERT may be a useful diagnostic marker for detecting the existence of malignant trophoblastic cells.

Telomerase activity; hTERT; hTR; Gestational trophoblastic disease; Hydatidiform mole

[1] Kirn N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L. et al.: "Specific association of human telornerase activity with immortal cells and cancer". Science, 1994, 266, 2011.

[2] Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P. et al.: "The RNA component of human telomerase". Science, 1995, 269, 1236.

[3] Damm K., Hemmann U., Garin-Chesa P., Hauel N., Kauffmann L, Priepke H. et al.: "A highly selective telomerase inh伽tor limiting human cancer cell proliferation". EMBO J., 2001, 20, 6958.

[4] Zaffaroni N., Villa R., Pennati M., Folini M.: "Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymes". Mini Rev. Med. Chem., 2003, 3, 51.

[5] Hiyama E., Gollahon L., Kataoka T., Kuroi K., Yokoyama T., Gazdar A.F. et al.: "Telomerase activity in human breast tumors". J. Natl Cancer Inst., 1996, 88, 116.

[6] Cheng R.Y., Yuen P.W., Nicholls J.M., Zheng Z., Wei W., Sham J.S. et al.: "Telomerase activation in nasopharyngeal carcinomas". Br. J. Cancer, 1998, 77, 456.

[7] Zhang D.K., Ngan H.Y., Cheng R.Y., Cheung A.N., Liu S.S., Tsao S.W.: "Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer". Eur. J. Cancer, 1999, 35, 154.

[8] Song H., Yang X., Xiang Y. (eds.): Trophoblastic Tumors Diagnosis & Treatment. China: People's Medical Publishing Press, 2004.

[9] Cheng R.Y., Yuen P.W., Nicholls J.M., Zheng Z., Wei W., Sham J.S. et al.: "Telomerase activation in nasopharyngeal carcinomas". Br. J. Cancer, 1998, 77, 456.

[10] Bradford M.M.: "A rapid and sensitive method for the quantification of microgram quantities". Anal. Biochem., 1976, 72, 248.

[11] McEachern M.J., Krauskopf, Blackburn E.H.: "Telomeres and their control". Annu. Rev. Genet., 2000, 34, 331.

[12] Rhyu M.S.: "Telomeres, telomerase and immortality". J. Natl Cancer Inst., 1995, 87, 884.

[13] Reddel R.R., Bryan T.M., Colgin L.M., Perrem K.T., Yeager T.R "Alternative lengthening of telomeres in human cells". Radial. Res., 2001, 155, 194.

[14] Takagi S., Kinouchi Y., Hiwatashi N., Chida M., Nagashima F., Takahashi S. et al.: "Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas". Cancer, 1999, 86, 1431.

[15] Chen R.J., Chu C.T., Huang S.C., Chow S.N., Hsieh C.Y.: "Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies". Hum. Reprod., 2002, 17, 463.

[16] Weinrich S.L., Pruzan R., Ma L., Ouellette M., Tesmer V.M., Holt S.E. et al.: " Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT' Nat. Genet., 1997, 17. 498.

[17] Kolquist K.A., Ellisen L.W., Counter C.M., Meyerson M., Tan L.K., Weinberg R.A. et al.: "Expression of TERT in early premalignant lesions and a subset of cells in normal tissues". Nat. Genet., 1998, 19, 182.

[18] Avilion A.A., Piatyszek M.A., Gupta J., Shay J.W., Bacchetti S., Greider C.W.: "Human telomerase activity in immortal cell lines and tumor tissues". Cancer Res., 1996, 56, 645.

[19] Roberts D.J., Mutter G.: "Advances in the molecular biology of gestational trophoblastic disease". J. Reprod. Med., 1994, 39, 201.

[20] Hong Z.S., Wu P.C.: "Studies in Trophoblastic Diseases in China" Oxford, Pergamon Press, 1988.

[21] Wang F., Kang X., Tan Y., Li Y.: "Preliminary study on c-Ha-ras oncogene mutations in hydatidiform mole tissues''. Reprod. Contracept., 2001, 12, 162.

[22] Wang F., Kang X., Pang J., Li Y.: "Expression of CD44 Variant 6 in hydatidiform mole and their relationship with development of postmolar tumor". Chinese J. Pract. Gynecol. Obstet., 2004, 20, 223.

[23] Sarkar S., Kacinski B.M., Kohorn E.I., Merino M.J., Carter D., Blakemore K.J.: "Demonstration of myc and ras oncogene expression by hybridization in situ in hydatidiform mole and in the BeWo chariocarcinoma cell line". Am. J. Obstet. Gynecol., 1986, 154, 390.

[24] Katagiri Y.U., Sleeman J., Fujii H., Herrlich P., Holla H., Tanaka K. et al.: "CD44 variants but not CD44s cooperate with b I-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis". Cancer Res., 1999, 59, 219.

[25] Amezcua C.A., Bahador A., Naidu Y.M., Felix J.C. TI: "Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydati山form moles". Am. J. Obstet. Gynecol., 2001, 184, 1441.